CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
CTIC
Delisted
CTIC was delisted on the 23rd of June, 2023.
79 hedge funds and large institutions have $76.7M invested in CTI BioPharma Corp. (DE) Common Stock in 2018 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 21 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
62% less capital invested
Capital invested by funds: $200M → $76.7M (-$124M)
Holders
79
Holding in Top 10
1
Calls
$119K
Puts
$21K
Top Buyers
| 1 | +$3M | |
| 2 | +$2.71M | |
| 3 | +$498K | |
| 4 |
CC
Caxton Corporation
Princeton,
New Jersey
|
+$427K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$334K |
Top Sellers
| 1 | -$17.3M | |
| 2 | -$4.36M | |
| 3 | -$3.37M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$3.25M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$3.01M |